Roche posts 'very good' results
21 Jul 2008
Roche has reported "very good" financial results for the past six months in its half-year review.
It said group sales increased by ten per cent in local currencies, while net income reached 5.7 billion Swiss francs (£2.8 billion).
The company has reaffirmed its targets for the year, anticipating a "high single-digit increase" in group sales over the whole year, excluding Tamiflu pandemic sales to governments and corporations.
Chief executive officer Severin Schwan commented that his firm had seen a particularly strong level of growth in the emerging markets.
He added: "Sales of our cancer portfolio and other key products in pharma and diagnostics are the main contributors to the strong performance."
Last month, Roche revealed it had been successful in its bid to increase its stake in Japanese pharmaceutical company Chugai.
The company reported it had increased its level of ownership from 50.1 per cent to 59.9 per cent.
